Return on equity (ROE) is the profit a company earns for every dollar of shareholder money invested in it, shown as a percentage. It is net income divided by shareholder equity, and the table shows both amounts: the profit earned and the equity it was earned on. A higher ROE means more profit per dollar of equity, but ROE also rises when equity shrinks through buybacks, dividends or losses, and it has no meaning for a company with negative equity. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.
MBX Biosciences, Inc. roe for the quarter ending 2026-06-30 was -25.47%, a change of 9.66% year-over-year.
MBX Biosciences, Inc. roe for the quarter ending 2026-03-31 was -19.78%, a change of 11.42% year-over-year.
MBX Biosciences, Inc. roe for the quarter ending 2025-12-31 was -23.56%, a change of 0.50% year-over-year.
MBX Biosciences, Inc. roe for the quarter ending 2025-09-30 was -20.77%, a change of -0.44% year-over-year.
MBX Biosciences, Inc. roe for fiscal 2025 was -23.56%, a change of 0.50% from fiscal 2024.
MBX Biosciences, Inc. roe for fiscal 2024 was -24.05%, a 153.53% decline from fiscal 2023.
MBX Biosciences, Inc. roe for fiscal 2023 was 44.93%.